Mealey's (October 8, 2021, 1:57 PM EDT) -- SAN FRANCISCO — The Ninth Circuit U.S. Court of Appeals ruled Oct. 7 that a district court properly found that no evidence supports a medical company’s claims that laboratories and doctors switched to a competitors’ blood tests based on false advertising, while a dissenting judge said the district court erred and that triable issues exist....